February
Albanese makes $8.5b Medicare overhaul his signature election policy
The prime minister will make Medicare the centrepiece of his re-election campaign, promising to spend big to eliminate patient costs for visits to the doctor.
$50m donation aims to foil ‘sneak thief of sight’
The University of Sydney has received its second major donation in just two weeks – this time to change the trajectory of 80 million glaucoma sufferers.
January
How Formula 1 engineers turbocharged a $200b public company
Australian CEOs are often shy to talk about how and when they use external consultants. The boss of this big French company, which plays an important role in Australia’s health system, isn’t.
Price must be right to put obesity drug on the PBS
It is vital the gatekeepers of the scheme hold the line on the cost benefits of blockbuster drugs.
December 2024
Mesoblast shares rocket on FDA approval, but CEO says risks remain
FDA approval for Mesoblast’s cell therapy used to treat children for complications that can occur during bone marrow transplants is a breakthrough for the biotech.
Sonic Healthcare to buy German lab group for $700m
Pathology giant Sonic Healthcare is buying one of Germany’s top medical lab groups as it seeks to expand its market share in Europe.
Pharmacy Guild sends voodoo dolls to fans and supporters
Trent Twomey doesn’t fear the scorn of the political establishment. Or the evil eye.
‘Focused, consistent’: How milk bar kids built $30b Chemist Warehouse
Chemist Warehouse founders Mario Verrocchi and Jack and Sam Gance have been named joint Business Person of the Year, alongside AirTrunk’s Robin Khuda.
Treating health funds like cash cows will be a disaster for our health system
If we want a sustainable private system, the next federal government must focus on reforms that put consumers before vested interests, to keep health insurance affordable.
November 2024
Young people pile into private health insurance
A surge in young people taking up private health cover drove membership to a record high in the September quarter, despite a cost-of-living crisis.
The Netflix model used for going to the doctor
The Challenger winner of the Business to Consumer category, Updoc, has delivered compound annual growth of 200 per cent.
October 2024
CSL pulls studies, trials on three therapies in late-stage setback
The biotech giant has not ruled out expanding its pipeline of treatments through acquisitions after a number of projects were put on hold.
Navis Capital prepares $1b-plus exit at Device Technologies
Latham is expected to use a successful exit of Device - which would also mark Navis Capital’s largest deal ever in Australia – to underpin the billion-dollar raise for his ninth fund in 2025.
Weight loss wars: a century on, the battle heats up
America’s Eli Lilly is locked in a fight with Denmark’s Novo Nordisk to control the weight loss market. One product could hold the key.
September 2024
I-MED bidders wrap their heads around data breach
The Permira-owned radiology giant has been the subject of media reports alleging data breaches and misuse of patient data.
BlackRock seeds $1.5b laboratory real estate fund
BlackRock is partnering with local private equity firm Wentworth Capital on a “pure play” laboratory fund that has already secured a number of seed assets
Pro Medicus’ billionaire boss says simplicity secret of success
Pro Medicus’ stranglehold on cloud-imaging healthcare tech means its growth trajectory has a long way to go.
Bugger off, Brookfield: Insurers hit back at private hospital chain
The increasingly bitter feud between insurers and private health operators is getting personal.
Echo IQ placement ‘oversubscribed’; Ord Minnett on ticket
Bids were due at market close on Thursday, and it is understood demand exceeded $10 million.
I took ecstasy at 50 and it changed my life
I got divorced, my father died, I cut ties with my mother, turned fifty, bought my first home of my own and did MDMA for the first time. This is an extract of the book that resulted.